Effects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial - Concepedia

Concepedia

Publication | Open Access

Effects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial

DOI Full Paper Access

23

Citations

11

References

2023

Year

Matias Trillini, Anna Caroli, Norberto Perico, Andrea Remuzzi, Paolo Brambilla, Giulia Villa, Annalisa Perna, Tobia Peracchi, Nadia Rubis, Davide Martinetti,

Clinical Journal of the American Society of Nephrology

Abstract

Tolvaptan-Octreotide LAR Combination in ADPKD (TOOL), NCT03541447.

References

	Year	Citations

Page 1